Deutsche Bank
VOR icon

Deutsche Bank’s Vor Biopharma VOR Stock Holding History

Deutsche Bank’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,592
Closed -$75.4K – 3706
2024
Q1 		$75.4K Hold
1,592
– – ﹤0.01% 3272
2023
Q4 		$71.6K Buy
+1,592
New +$65.7K ﹤0.01% 3352
2022
Q2 		– Sell
-531
Closed -$64K – 4339
2022
Q1 		$64K Sell
531
-61
-10% -$10.4K ﹤0.01% 3757
2021
Q4 		$138K Buy
592
+30
+5% +$8.65K ﹤0.01% 3557
2021
Q3 		$176K Buy
562
+198
+54% +$58.9K ﹤0.01% 3632
2021
Q2 		$136K Sell
364
-11
-3% -$5.43K ﹤0.01% 4001
2021
Q1 		$324K Buy
+375
New +$317K ﹤0.01% 3371

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank's VOR Position: Q2 2024 in Review

Deutsche Bank sold out of Vor Biopharma (VOR) in Q2 2024, closing a stake of 1,592 shares — an estimated $75.4K sold.

Deutsche Bank first reported a position in VOR in Q1 2021 and held it in 7 quarters. The position peaked at $324K in Q1 2021. 71 funds tracked by Wall St. Rank hold VOR as of Q2 2024.

  • Deutsche Bank reported no remaining Vor Biopharma position as of Q2 2024 after selling out during the quarter.
  • Deutsche Bank sold 1,592 Vor Biopharma shares in Q2 2024, an estimated $75.4K.
  • Deutsche Bank first reported a position in Vor Biopharma in Q1 2021 and held it in 7 quarters.
  • Deutsche Bank's Vor Biopharma position peaked at $324K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.